The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Mesalamine, also known as Mesalamine, or 5-aminosalicylic acid (5-ASA), is a medication used to treat inflammatory bowel disease, including ulcerative colitis and Crohn's disease. It is generally used for mildly to moderately severe disease. It is taken by mouth or rectally. The formulations which are taken by mouth appear to be similarly effective.
The global Mesalamine market was valued at US$ 156.5 million in 2023 and is anticipated to reach US$ 195.6 million by 2030, witnessing a CAGR of 3.2% during the forecast period 2024-2030.
The industry's leading manufacturers are Syntese A/S, Divis Laboratories, ipca Laboratories and Cambrex Corporation, which accounted for 23.74%, 14.71%, 6.44% and 6.35% of the global revenue share in 2019, respectively.
In terms of regions, the revenue share of Europe is the highest, reaching 41.11% in 2019.
This report aims to provide a comprehensive presentation of the global market for Mesalamine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Mesalamine.
Report Scope
The Mesalamine market size, estimations, and forecasts are provided in terms of sales volume (MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Mesalamine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Mesalamine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Syntese A/S
Divis Laboratories
Cambrex Corporation
Ipca Laboratories
Hangzhou Brother
PharmaZell
Lianyungang Fengheng Biopharm
Lasa Loboratory
Erregierre SpA
Corden Pharma Bergamo
CTX Lifescience
Ishita Active Pharma Ingredients
YC Biotech (Jiangsu)
Xinxiang Tianfeng Fine Chemical
Segment by Type
Purity ≥ 97%
Purity ≥ 98%
Purity ≥ 99%
Segment by Application
Mesalazine Tablets
Mesalazine Capsules
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Mesalamine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Mesalamine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Mesalamine, also known as Mesalamine, or 5-aminosalicylic acid (5-ASA), is a medication used to treat inflammatory bowel disease, including ulcerative colitis and Crohn's disease. It is generally used for mildly to moderately severe disease. It is taken by mouth or rectally. The formulations which are taken by mouth appear to be similarly effective.
The global Mesalamine market was valued at US$ 156.5 million in 2023 and is anticipated to reach US$ 195.6 million by 2030, witnessing a CAGR of 3.2% during the forecast period 2024-2030.
The industry's leading manufacturers are Syntese A/S, Divis Laboratories, ipca Laboratories and Cambrex Corporation, which accounted for 23.74%, 14.71%, 6.44% and 6.35% of the global revenue share in 2019, respectively.
In terms of regions, the revenue share of Europe is the highest, reaching 41.11% in 2019.
This report aims to provide a comprehensive presentation of the global market for Mesalamine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Mesalamine.
Report Scope
The Mesalamine market size, estimations, and forecasts are provided in terms of sales volume (MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Mesalamine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Mesalamine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Syntese A/S
Divis Laboratories
Cambrex Corporation
Ipca Laboratories
Hangzhou Brother
PharmaZell
Lianyungang Fengheng Biopharm
Lasa Loboratory
Erregierre SpA
Corden Pharma Bergamo
CTX Lifescience
Ishita Active Pharma Ingredients
YC Biotech (Jiangsu)
Xinxiang Tianfeng Fine Chemical
Segment by Type
Purity ≥ 97%
Purity ≥ 98%
Purity ≥ 99%
Segment by Application
Mesalazine Tablets
Mesalazine Capsules
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Mesalamine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Mesalamine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Mesalamine Market Overview
1.1 Product Overview and Scope of Mesalamine
1.2 Mesalamine Segment by Type
1.2.1 Global Mesalamine Market Value Comparison by Type (2024-2030)
1.2.2 Purity ≥ 97%
1.2.3 Purity ≥ 98%
1.2.4 Purity ≥ 99%
1.3 Mesalamine Segment by Application
1.3.1 Global Mesalamine Market Value by Application: (2024-2030)
1.3.2 Mesalazine Tablets
1.3.3 Mesalazine Capsules
1.3.4 Others
1.4 Global Mesalamine Market Size Estimates and Forecasts
1.4.1 Global Mesalamine Revenue 2019-2030
1.4.2 Global Mesalamine Sales 2019-2030
1.4.3 Global Mesalamine Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Mesalamine Market Competition by Manufacturers
2.1 Global Mesalamine Sales Market Share by Manufacturers (2019-2024)
2.2 Global Mesalamine Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Mesalamine Average Price by Manufacturers (2019-2024)
2.4 Global Mesalamine Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Mesalamine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Mesalamine, Product Type & Application
2.7 Mesalamine Market Competitive Situation and Trends
2.7.1 Mesalamine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Mesalamine Players Market Share by Revenue
2.7.3 Global Mesalamine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Mesalamine Retrospective Market Scenario by Region
3.1 Global Mesalamine Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Mesalamine Global Mesalamine Sales by Region: 2019-2030
3.2.1 Global Mesalamine Sales by Region: 2019-2024
3.2.2 Global Mesalamine Sales by Region: 2025-2030
3.3 Global Mesalamine Global Mesalamine Revenue by Region: 2019-2030
3.3.1 Global Mesalamine Revenue by Region: 2019-2024
3.3.2 Global Mesalamine Revenue by Region: 2025-2030
3.4 North America Mesalamine Market Facts & Figures by Country
3.4.1 North America Mesalamine Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Mesalamine Sales by Country (2019-2030)
3.4.3 North America Mesalamine Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Mesalamine Market Facts & Figures by Country
3.5.1 Europe Mesalamine Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Mesalamine Sales by Country (2019-2030)
3.5.3 Europe Mesalamine Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Mesalamine Market Facts & Figures by Country
3.6.1 Asia Pacific Mesalamine Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Mesalamine Sales by Country (2019-2030)
3.6.3 Asia Pacific Mesalamine Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Mesalamine Market Facts & Figures by Country
3.7.1 Latin America Mesalamine Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Mesalamine Sales by Country (2019-2030)
3.7.3 Latin America Mesalamine Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Mesalamine Market Facts & Figures by Country
3.8.1 Middle East and Africa Mesalamine Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Mesalamine Sales by Country (2019-2030)
3.8.3 Middle East and Africa Mesalamine Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Mesalamine Sales by Type (2019-2030)
4.1.1 Global Mesalamine Sales by Type (2019-2024)
4.1.2 Global Mesalamine Sales by Type (2025-2030)
4.1.3 Global Mesalamine Sales Market Share by Type (2019-2030)
4.2 Global Mesalamine Revenue by Type (2019-2030)
4.2.1 Global Mesalamine Revenue by Type (2019-2024)
4.2.2 Global Mesalamine Revenue by Type (2025-2030)
4.2.3 Global Mesalamine Revenue Market Share by Type (2019-2030)
4.3 Global Mesalamine Price by Type (2019-2030)
5 Segment by Application
5.1 Global Mesalamine Sales by Application (2019-2030)
5.1.1 Global Mesalamine Sales by Application (2019-2024)
5.1.2 Global Mesalamine Sales by Application (2025-2030)
5.1.3 Global Mesalamine Sales Market Share by Application (2019-2030)
5.2 Global Mesalamine Revenue by Application (2019-2030)
5.2.1 Global Mesalamine Revenue by Application (2019-2024)
5.2.2 Global Mesalamine Revenue by Application (2025-2030)
5.2.3 Global Mesalamine Revenue Market Share by Application (2019-2030)
5.3 Global Mesalamine Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Syntese A/S
6.1.1 Syntese A/S Corporation Information
6.1.2 Syntese A/S Description and Business Overview
6.1.3 Syntese A/S Mesalamine Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Syntese A/S Mesalamine Product Portfolio
6.1.5 Syntese A/S Recent Developments/Updates
6.2 Divis Laboratories
6.2.1 Divis Laboratories Corporation Information
6.2.2 Divis Laboratories Description and Business Overview
6.2.3 Divis Laboratories Mesalamine Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Divis Laboratories Mesalamine Product Portfolio
6.2.5 Divis Laboratories Recent Developments/Updates
6.3 Cambrex Corporation
6.3.1 Cambrex Corporation Corporation Information
6.3.2 Cambrex Corporation Description and Business Overview
6.3.3 Cambrex Corporation Mesalamine Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Cambrex Corporation Mesalamine Product Portfolio
6.3.5 Cambrex Corporation Recent Developments/Updates
6.4 Ipca Laboratories
6.4.1 Ipca Laboratories Corporation Information
6.4.2 Ipca Laboratories Description and Business Overview
6.4.3 Ipca Laboratories Mesalamine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Ipca Laboratories Mesalamine Product Portfolio
6.4.5 Ipca Laboratories Recent Developments/Updates
6.5 Hangzhou Brother
6.5.1 Hangzhou Brother Corporation Information
6.5.2 Hangzhou Brother Description and Business Overview
6.5.3 Hangzhou Brother Mesalamine Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Hangzhou Brother Mesalamine Product Portfolio
6.5.5 Hangzhou Brother Recent Developments/Updates
6.6 PharmaZell
6.6.1 PharmaZell Corporation Information
6.6.2 PharmaZell Description and Business Overview
6.6.3 PharmaZell Mesalamine Sales, Revenue and Gross Margin (2019-2024)
6.6.4 PharmaZell Mesalamine Product Portfolio
6.6.5 PharmaZell Recent Developments/Updates
6.7 Lianyungang Fengheng Biopharm
6.6.1 Lianyungang Fengheng Biopharm Corporation Information
6.6.2 Lianyungang Fengheng Biopharm Description and Business Overview
6.6.3 Lianyungang Fengheng Biopharm Mesalamine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Lianyungang Fengheng Biopharm Mesalamine Product Portfolio
6.7.5 Lianyungang Fengheng Biopharm Recent Developments/Updates
6.8 Lasa Loboratory
6.8.1 Lasa Loboratory Corporation Information
6.8.2 Lasa Loboratory Description and Business Overview
6.8.3 Lasa Loboratory Mesalamine Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Lasa Loboratory Mesalamine Product Portfolio
6.8.5 Lasa Loboratory Recent Developments/Updates
6.9 Erregierre SpA
6.9.1 Erregierre SpA Corporation Information
6.9.2 Erregierre SpA Description and Business Overview
6.9.3 Erregierre SpA Mesalamine Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Erregierre SpA Mesalamine Product Portfolio
6.9.5 Erregierre SpA Recent Developments/Updates
6.10 Corden Pharma Bergamo
6.10.1 Corden Pharma Bergamo Corporation Information
6.10.2 Corden Pharma Bergamo Description and Business Overview
6.10.3 Corden Pharma Bergamo Mesalamine Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Corden Pharma Bergamo Mesalamine Product Portfolio
6.10.5 Corden Pharma Bergamo Recent Developments/Updates
6.11 CTX Lifescience
6.11.1 CTX Lifescience Corporation Information
6.11.2 CTX Lifescience Mesalamine Description and Business Overview
6.11.3 CTX Lifescience Mesalamine Sales, Revenue and Gross Margin (2019-2024)
6.11.4 CTX Lifescience Mesalamine Product Portfolio
6.11.5 CTX Lifescience Recent Developments/Updates
6.12 Ishita Active Pharma Ingredients
6.12.1 Ishita Active Pharma Ingredients Corporation Information
6.12.2 Ishita Active Pharma Ingredients Mesalamine Description and Business Overview
6.12.3 Ishita Active Pharma Ingredients Mesalamine Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Ishita Active Pharma Ingredients Mesalamine Product Portfolio
6.12.5 Ishita Active Pharma Ingredients Recent Developments/Updates
6.13 YC Biotech (Jiangsu)
6.13.1 YC Biotech (Jiangsu) Corporation Information
6.13.2 YC Biotech (Jiangsu) Mesalamine Description and Business Overview
6.13.3 YC Biotech (Jiangsu) Mesalamine Sales, Revenue and Gross Margin (2019-2024)
6.13.4 YC Biotech (Jiangsu) Mesalamine Product Portfolio
6.13.5 YC Biotech (Jiangsu) Recent Developments/Updates
6.14 Xinxiang Tianfeng Fine Chemical
6.14.1 Xinxiang Tianfeng Fine Chemical Corporation Information
6.14.2 Xinxiang Tianfeng Fine Chemical Mesalamine Description and Business Overview
6.14.3 Xinxiang Tianfeng Fine Chemical Mesalamine Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Xinxiang Tianfeng Fine Chemical Mesalamine Product Portfolio
6.14.5 Xinxiang Tianfeng Fine Chemical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Mesalamine Industry Chain Analysis
7.2 Mesalamine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Mesalamine Production Mode & Process
7.4 Mesalamine Sales and Marketing
7.4.1 Mesalamine Sales Channels
7.4.2 Mesalamine Distributors
7.5 Mesalamine Customers
8 Mesalamine Market Dynamics
8.1 Mesalamine Industry Trends
8.2 Mesalamine Market Drivers
8.3 Mesalamine Market Challenges
8.4 Mesalamine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Mesalamine Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Mesalamine Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Mesalamine Market Competitive Situation by Manufacturers in 2023
Table 4. Global Mesalamine Sales (MT) of Key Manufacturers (2019-2024)
Table 5. Global Mesalamine Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Mesalamine Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Mesalamine Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Mesalamine Average Price (USD/Kg) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Mesalamine, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Mesalamine, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Mesalamine, Product Type & Application
Table 12. Global Key Manufacturers of Mesalamine, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Mesalamine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mesalamine as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Mesalamine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Mesalamine Sales by Region (2019-2024) & (MT)
Table 18. Global Mesalamine Sales Market Share by Region (2019-2024)
Table 19. Global Mesalamine Sales by Region (2025-2030) & (MT)
Table 20. Global Mesalamine Sales Market Share by Region (2025-2030)
Table 21. Global Mesalamine Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Mesalamine Revenue Market Share by Region (2019-2024)
Table 23. Global Mesalamine Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Mesalamine Revenue Market Share by Region (2025-2030)
Table 25. North America Mesalamine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Mesalamine Sales by Country (2019-2024) & (MT)
Table 27. North America Mesalamine Sales by Country (2025-2030) & (MT)
Table 28. North America Mesalamine Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Mesalamine Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Mesalamine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Mesalamine Sales by Country (2019-2024) & (MT)
Table 32. Europe Mesalamine Sales by Country (2025-2030) & (MT)
Table 33. Europe Mesalamine Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Mesalamine Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Mesalamine Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Mesalamine Sales by Region (2019-2024) & (MT)
Table 37. Asia Pacific Mesalamine Sales by Region (2025-2030) & (MT)
Table 38. Asia Pacific Mesalamine Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Mesalamine Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Mesalamine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Mesalamine Sales by Country (2019-2024) & (MT)
Table 42. Latin America Mesalamine Sales by Country (2025-2030) & (MT)
Table 43. Latin America Mesalamine Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Mesalamine Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Mesalamine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Mesalamine Sales by Country (2019-2024) & (MT)
Table 47. Middle East & Africa Mesalamine Sales by Country (2025-2030) & (MT)
Table 48. Middle East & Africa Mesalamine Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Mesalamine Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Mesalamine Sales (MT) by Type (2019-2024)
Table 51. Global Mesalamine Sales (MT) by Type (2025-2030)
Table 52. Global Mesalamine Sales Market Share by Type (2019-2024)
Table 53. Global Mesalamine Sales Market Share by Type (2025-2030)
Table 54. Global Mesalamine Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Mesalamine Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Mesalamine Revenue Market Share by Type (2019-2024)
Table 57. Global Mesalamine Revenue Market Share by Type (2025-2030)
Table 58. Global Mesalamine Price (USD/Kg) by Type (2019-2024)
Table 59. Global Mesalamine Price (USD/Kg) by Type (2025-2030)
Table 60. Global Mesalamine Sales (MT) by Application (2019-2024)
Table 61. Global Mesalamine Sales (MT) by Application (2025-2030)
Table 62. Global Mesalamine Sales Market Share by Application (2019-2024)
Table 63. Global Mesalamine Sales Market Share by Application (2025-2030)
Table 64. Global Mesalamine Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Mesalamine Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Mesalamine Revenue Market Share by Application (2019-2024)
Table 67. Global Mesalamine Revenue Market Share by Application (2025-2030)
Table 68. Global Mesalamine Price (USD/Kg) by Application (2019-2024)
Table 69. Global Mesalamine Price (USD/Kg) by Application (2025-2030)
Table 70. Syntese A/S Corporation Information
Table 71. Syntese A/S Description and Business Overview
Table 72. Syntese A/S Mesalamine Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 73. Syntese A/S Mesalamine Product
Table 74. Syntese A/S Recent Developments/Updates
Table 75. Divis Laboratories Corporation Information
Table 76. Divis Laboratories Description and Business Overview
Table 77. Divis Laboratories Mesalamine Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 78. Divis Laboratories Mesalamine Product
Table 79. Divis Laboratories Recent Developments/Updates
Table 80. Cambrex Corporation Corporation Information
Table 81. Cambrex Corporation Description and Business Overview
Table 82. Cambrex Corporation Mesalamine Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 83. Cambrex Corporation Mesalamine Product
Table 84. Cambrex Corporation Recent Developments/Updates
Table 85. Ipca Laboratories Corporation Information
Table 86. Ipca Laboratories Description and Business Overview
Table 87. Ipca Laboratories Mesalamine Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 88. Ipca Laboratories Mesalamine Product
Table 89. Ipca Laboratories Recent Developments/Updates
Table 90. Hangzhou Brother Corporation Information
Table 91. Hangzhou Brother Description and Business Overview
Table 92. Hangzhou Brother Mesalamine Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 93. Hangzhou Brother Mesalamine Product
Table 94. Hangzhou Brother Recent Developments/Updates
Table 95. PharmaZell Corporation Information
Table 96. PharmaZell Description and Business Overview
Table 97. PharmaZell Mesalamine Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 98. PharmaZell Mesalamine Product
Table 99. PharmaZell Recent Developments/Updates
Table 100. Lianyungang Fengheng Biopharm Corporation Information
Table 101. Lianyungang Fengheng Biopharm Description and Business Overview
Table 102. Lianyungang Fengheng Biopharm Mesalamine Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 103. Lianyungang Fengheng Biopharm Mesalamine Product
Table 104. Lianyungang Fengheng Biopharm Recent Developments/Updates
Table 105. Lasa Loboratory Corporation Information
Table 106. Lasa Loboratory Description and Business Overview
Table 107. Lasa Loboratory Mesalamine Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 108. Lasa Loboratory Mesalamine Product
Table 109. Lasa Loboratory Recent Developments/Updates
Table 110. Erregierre SpA Corporation Information
Table 111. Erregierre SpA Description and Business Overview
Table 112. Erregierre SpA Mesalamine Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 113. Erregierre SpA Mesalamine Product
Table 114. Erregierre SpA Recent Developments/Updates
Table 115. Corden Pharma Bergamo Corporation Information
Table 116. Corden Pharma Bergamo Description and Business Overview
Table 117. Corden Pharma Bergamo Mesalamine Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 118. Corden Pharma Bergamo Mesalamine Product
Table 119. Corden Pharma Bergamo Recent Developments/Updates
Table 120. CTX Lifescience Corporation Information
Table 121. CTX Lifescience Description and Business Overview
Table 122. CTX Lifescience Mesalamine Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 123. CTX Lifescience Mesalamine Product
Table 124. CTX Lifescience Recent Developments/Updates
Table 125. Ishita Active Pharma Ingredients Corporation Information
Table 126. Ishita Active Pharma Ingredients Description and Business Overview
Table 127. Ishita Active Pharma Ingredients Mesalamine Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 128. Ishita Active Pharma Ingredients Mesalamine Product
Table 129. Ishita Active Pharma Ingredients Recent Developments/Updates
Table 130. YC Biotech (Jiangsu) Corporation Information
Table 131. YC Biotech (Jiangsu) Description and Business Overview
Table 132. YC Biotech (Jiangsu) Mesalamine Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 133. YC Biotech (Jiangsu) Mesalamine Product
Table 134. YC Biotech (Jiangsu) Recent Developments/Updates
Table 135. Xinxiang Tianfeng Fine Chemical Corporation Information
Table 136. Xinxiang Tianfeng Fine Chemical Description and Business Overview
Table 137. Xinxiang Tianfeng Fine Chemical Mesalamine Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 138. Xinxiang Tianfeng Fine Chemical Mesalamine Product
Table 139. Xinxiang Tianfeng Fine Chemical Recent Developments/Updates
Table 140. Key Raw Materials Lists
Table 141. Raw Materials Key Suppliers Lists
Table 142. Mesalamine Distributors List
Table 143. Mesalamine Customers List
Table 144. Mesalamine Market Trends
Table 145. Mesalamine Market Drivers
Table 146. Mesalamine Market Challenges
Table 147. Mesalamine Market Restraints
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Mesalamine
Figure 2. Global Mesalamine Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Mesalamine Market Share by Type in 2023 & 2030
Figure 4. Purity ≥ 97% Product Picture
Figure 5. Purity ≥ 98% Product Picture
Figure 6. Purity ≥ 99% Product Picture
Figure 7. Global Mesalamine Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Mesalamine Market Share by Application in 2023 & 2030
Figure 9. Mesalazine Tablets
Figure 10. Mesalazine Capsules
Figure 11. Others
Figure 12. Global Mesalamine Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Mesalamine Market Size (2019-2030) & (US$ Million)
Figure 14. Global Mesalamine Sales (2019-2030) & (MT)
Figure 15. Global Mesalamine Average Price (USD/Kg) & (2019-2030)
Figure 16. Mesalamine Report Years Considered
Figure 17. Mesalamine Sales Share by Manufacturers in 2023
Figure 18. Global Mesalamine Revenue Share by Manufacturers in 2023
Figure 19. The Global 5 and 10 Largest Mesalamine Players: Market Share by Revenue in 2023
Figure 20. Mesalamine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 21. Global Mesalamine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 22. North America Mesalamine Sales Market Share by Country (2019-2030)
Figure 23. North America Mesalamine Revenue Market Share by Country (2019-2030)
Figure 24. U.S. Mesalamine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Canada Mesalamine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 26. Europe Mesalamine Sales Market Share by Country (2019-2030)
Figure 27. Europe Mesalamine Revenue Market Share by Country (2019-2030)
Figure 28. Germany Mesalamine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. France Mesalamine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. U.K. Mesalamine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Italy Mesalamine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Russia Mesalamine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Asia Pacific Mesalamine Sales Market Share by Region (2019-2030)
Figure 34. Asia Pacific Mesalamine Revenue Market Share by Region (2019-2030)
Figure 35. China Mesalamine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. Japan Mesalamine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. South Korea Mesalamine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. India Mesalamine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Australia Mesalamine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Taiwan Mesalamine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Indonesia Mesalamine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Thailand Mesalamine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Malaysia Mesalamine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Philippines Mesalamine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Latin America Mesalamine Sales Market Share by Country (2019-2030)
Figure 46. Latin America Mesalamine Revenue Market Share by Country (2019-2030)
Figure 47. Mexico Mesalamine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Brazil Mesalamine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Argentina Mesalamine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Middle East & Africa Mesalamine Sales Market Share by Country (2019-2030)
Figure 51. Middle East & Africa Mesalamine Revenue Market Share by Country (2019-2030)
Figure 52. Turkey Mesalamine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Saudi Arabia Mesalamine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. UAE Mesalamine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 55. Global Sales Market Share of Mesalamine by Type (2019-2030)
Figure 56. Global Revenue Market Share of Mesalamine by Type (2019-2030)
Figure 57. Global Mesalamine Price (USD/Kg) by Type (2019-2030)
Figure 58. Global Sales Market Share of Mesalamine by Application (2019-2030)
Figure 59. Global Revenue Market Share of Mesalamine by Application (2019-2030)
Figure 60. Global Mesalamine Price (USD/Kg) by Application (2019-2030)
Figure 61. Mesalamine Value Chain
Figure 62. Mesalamine Production Process
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Distributors Profiles
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
